Agenus(FRA) AJ81

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

N/A

Agenus Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$113.78

Net Income (TTM)

$78.60

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

AJ81 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Agenus

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Garo H. Armen, PhD

Website

www.agenusbio.com

AJ81 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Agenus Performance Analysis

Agenus annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 93,269,644	-62.7%
2023	2023-12-31	USD 144,585,833	55.0%
2024	2024-12-31	USD 95,649,334	-33.8%
2025	2025-12-31	USD 101,185,744	5.8%

Agenus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -14.88	734.0%
2023	2023-12-31	USD -12.71	-14.5%
2024	2024-12-31	USD -9.79	-23.0%
2025	2025-12-31	USD -0.00	-100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$29.69

+1.3%

Gross Profit

$29.24

+1.5%

Gross Margin

98.50%

+1.1%

Market Cap

N/A

Market Cap/Employee

$1.39

N/A

Employees

N/A

Net Income

-$0.49

+0.0%

EBITDA

$10.16

-0.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$270.19

-23.1%

Total Debt

$253.80

+0.7%

Accounts Receivable

$41.62

+68.9%

Inventory

$0.00

N/A

Long Term Debt

$127.12

+0.5%

Short Term Debt

$126.69

+1.3%

Return on Assets

50.94%

-0.7%

Return on Invested Capital

136.28%

N/A

Free Cash Flow

-$27.02

+1.7%

Operating Cash Flow

-$27.02

+1.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About AJ81

What is the current price of Agenus?

Agenus is trading at N/A per share.

What is the 52-week range for Agenus?

Over the past 52 weeks, Agenus has traded between N/A and N/A.

How much debt does Agenus have?

As of the most recent reporting period, Agenus reported total debt of $253.80M.

How much cash does Agenus have on hand?

Agenus reported $16.39M in cash and cash equivalents in its most recent financial results.

What is Agenus’s dividend yield?

Agenus does not currently have a dividend yield.

Agenus(FRA) AJ81

Agenus Financials at a Glance

AJ81 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Agenus

AJ81 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Agenus Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AJ81

What is the current price of Agenus?

What is the 52-week range for Agenus?

How much debt does Agenus have?

How much cash does Agenus have on hand?

What is Agenus’s dividend yield?

Premium Investing Services